Serum and follicular resistin levels in women with polycystic ovarian syndrome during IVF-stimulated cycles

Human Reproduction

Volumn 20, Issue 1, 2005, Pages 117-121

  Seow, Kok Min ^a,b   Juan, Chi Chang ^b,c   Hsu, Yung Pei ^c   Ho, Low Tone ^b,c   Wang, Yuan Yung ^a   Hwang, Jiann Loung ^d,e  

^a E DA HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Follicular fluid; IVF; Polycystic ovarian syndrome; Resistin

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GLUCOSE; GONADORELIN DERIVATIVE; HUMAN MENOPAUSAL GONADOTROPIN; INSULIN; LUTEINIZING HORMONE; RESISTIN; SUPERMON; UROFOLLITROPIN;

ADULT; AGE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LUTEINIZING HORMONE BLOOD LEVEL; NIDATION; OOCYTE DEVELOPMENT; OOCYTE MATURATION; ORAL GLUCOSE TOLERANCE TEST; OUTCOMES RESEARCH; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; OVULATION; OVULATION INDUCTION; PREGNANCY RATE; SPONTANEOUS ABORTION;

EID: 12444303312     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh589     Document Type: Article

References (34)

1. Adams J, Polson DW and Franks S (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 293, 355-359.
2. Adashi EY (1994) Growth factors and ovarian function: the IGF-I paradigm. Horm Res 42,44-48.
3. Amato G, Conte M, Mazziotti G, Lalli E, Vitolo G, Tucker AT, Bellastella A, Carella C and Izzo A (2003) Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstet Gynecol 101, 1177-1182.
4. Balen AH, Tan SL, MacDougall J and Jacobs HS (1993) Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod 8,959-964.
5. Brannström M and Norman RJ (1993) Involvement of leukocytes and cytokines in the ovulatory process and corpus luteum function. Hum Reprod 8,1762-1775.
6. Burghen GA, Givens JR and Kitabchi AE (1980) Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 50,113-116.
7. Chang RJ, Nakamura RM, Judd HL and Kaplan SA (1983) Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 57,356-359.
8. Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18,774-800.
9. Dunaif A, Green G, Phelps RG, Lebwohl M, Futterweit W and Lewy L (1991) Acanthosis nigricans, insulin action and hyperandrogenism: clinical, histological and biochemical findings. J Clin Endocrinol Metab 73,590-595.
10. Fedorcsak P, Storeng R, Dale PO, Tanbo T and Abyholm T (2000) Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand 79,43-48.
11. Fox R, Corrigan E, Thomas PG and Hull MG (1991) Oestrogen and androgen states in oligo-amenorrhoeic women with polycystic ovaries. Br J Obstet Gynecol 98,294-299.
12. Franks S (1995) Polycystic ovary syndrome. N Engl J Med 333,853-861.
13. Ghazeeri G, Kutteh WH, Bryer-Ash M, Haas D and Ke RW (2003) Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome. Fertil Steril 79,562-566.
14. Glueck CJ, Philips HG, Cameron D, Sieve-Smith L and Wang P (2001) Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril 75,46-52.
15. Hasegawa I, Murakawa H, Suzuki M, Yamamoto Y, Kurabayashi T and Tanaka K (1999) Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome. Fertil Steril 71,323-327.
16. Homburg R, Armar NA, Eshel A, Adams J and Jacobs HS (1988) Influence of serum luteinising hormone concentrations on ovulation, conception and early pregnancy loss in polycystic ovary syndrome. Br Med J 297, 1024-1026.
17. Homburg R, Levy T, Berkovitz D, Farchi J, Feldberg D, Ashkenazi J and Ben-Rafael Z (1993) Gonadotrophin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome. Fertil Steril 59,527-531.
18. Lédée-Bataille N, Laprée-Delage, Taupin JL, Dubanchet S, Taieb J, Moreau JF and Chaouat G (2001) Follicular fluid concentration of leukaemia inhibitory factor is decreased among women with polycystic ovary syndrome during assisted reproduction cycles. Hum Reprod 10,2073-2078.
19. Legro RS, Kunselman AR, Dodson WC and Dunaif A (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84,165-169.
20. Lobo RA, Gysler M, March CM, Goebelsmann U and Mishell DR, Jr (1982) Clinical and laboratory predictors of clomiphene response. Fertil Stril 37,168-174.
21. Mantzoros CS, Cramer DW, Liberman RF and Barbieri RL (2000) Predictive values of serum and follicular fluid leptin concentrations during assisted reproductive cycles in normal women and in women with the polycystic ovarian syndrome. Hum Reprod 15,539-544.
22. Matsuda M and DeFronzo R (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22,1462-1470.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF and Turner RC (1985) Homeostasis model assessment: insulin resistance and [beta]-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28,412-419.
24. Nestler JE, Jakubowicz DJ, Evans WS and Pasquali R (1998) Effects metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 338,1876-1880.
25. Orio F, Jr, Palomba S, Cascella T, Milan G, Mioni R, Pagano C, Zullo F, Colao A and Lombardi Vettor R (2004) Adiponectin levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88,2619-2623.
26. Panidis D, Koliakos G, Kourtis A, Farmakiots D, Mouslech T and Rousso D (2004) Serum resistin levels in women with polycystic ovary syndrome. Fertil Steril 81,361-366.
27. Rodbell M (1964) Metabolism of isolated fat cell. I. Effects of hormone on glucose metabolism and lipolysis. J Biol Chem 239,375-380.
28. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19, 41-47.
29. Seow KM, Juan CC, Wu YL, Hsu YP, Yang WM, Tsai YL, Hwang JL and Ho LT (2004) Serum and adipocyte resistin in polycystic ovarian syndrome with insulin resistance. Hum Reprod 19,48-53.
30. Shepard MK, Balmaceda JP and Leija CG (1979) Relationship of weight to successful induction of ovulation with clomiphene citrate. Fertil Steril 32,641-645.
31. Shoupe D, Kumar DD and Lobo RA (1983) Insulin resistance in polycystic ovary syndrome. Am J Obstet Gynecol 147,588-592.
32. Smitz J, Ron-El R and Tarlatzis BC (1992) The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centers. Hum Reprod 7 (Suppl 1),49-66.
33. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wirght CM, Patel HR, Ahima RS and Lazar MA (2001) The hormone resistin links obesity to diabetes. Nature 409,307-312.
34. Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW and Nestler JE (2001) Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril 75,310-315.